WILMINGTON, Mass., October 03, 2024--Charles River previews SfN 2024, including the latest developments in CNS research and innovative approaches to tackling neurodegenerative disorders.
WILMINGTON, Mass., October 02, 2024--Charles River and Lundbeck enter agreement to utilize AI-powered Logica to advance the discovery of novel drugs for neurological disease.
Charles River Laboratories International's (NYSE:CRL) stock is up by 1.0% over the past week. Given that the market...